investorscraft@gmail.com

Investing in Medpace Holdings, Inc. (MEDP)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/a
Intrinsic value (DCF)125.24-64
Graham-Dodd Method41.45-88
Graham Formula331.63-4

Company description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
HomeMenuAccount